Introduction {#s1}
============

The ankle-brachial pressure index (ABI), which is the ratio of ankle to brachial systolic blood pressure, is the golden standard for the diagnosis of peripheral arterial disease (PAD) and is a highly specific method for the assessment of vascular risk in otherwise asymptomatic patients [@pone.0015181-Doobay1]. The American Heart Association (AHA) Prevention Conference V suggested that the ABI is a strong and independent risk factor for cardiovascular mortality and recommended it be used to detect subclinical disease in the prevention of cardiovascular mortality and stroke [@pone.0015181-Greenland1]--[@pone.0015181-Smith1]. An ABI value \<0.9 is widely acknowledged to indicate an abnormally low level [@pone.0015181-Doobay2] and several studies have shown that a low ABI was an independent predictor of increased risk of fatal myocardial infarction [@pone.0015181-Newman1] and increased risk of cardiovascular disease (CVD) mortality [@pone.0015181-Newman2]. And the ABI provides a simple measurement that can be performed in primary care settings without expensive or elaborate equipment or extensive training or experience [@pone.0015181-Migliacci1]. Therefore, much research focus on the relationship between ABI and CVD recently [@pone.0015181-Wild1], [@pone.0015181-Laurin1].

Many studies indicated that excessive alcohol intake maybe result in poor health outcome, especially cardiovascular disease [@pone.0015181-Fagrell1], [@pone.0015181-Corrao1], but moderate drinking was associated with cardiovascular protective effects [@pone.0015181-OKeefe1], [@pone.0015181-DiCastelnuovo1]. Nevertheless, up to date, the relationship between ABI, an independent predictor of CVD, with alcohol intake remains unclear. In the present study, we investigated the relationship between alcohol consumption and ABI in Chinese population.

Results {#s2}
=======

Characteristics of Study Participants {#s2a}
-------------------------------------

The characteristics of study participants were shown in [table 1](#pone-0015181-t001){ref-type="table"}. The mean age, BMI, triglyceride, total cholesterol, SBP, DBP and uric acid was difference between each ethnic group in both men and women (all *P*\<0.01). The HDL cholesterol, was difference in men (*P* = 0.007) but not in women (*P* = 0.099), and fasting glucose was difference in men (*P*\<0.001) but not in women (*P* = 0.113).

According to the amount of alcohol intake, we categorized the study population into six categories according to previous reported [@pone.0015181-Schminke1], whose characteristics were shown in [table 2](#pone-0015181-t002){ref-type="table"} and [table 3](#pone-0015181-t003){ref-type="table"}. In both men and women, there were significantly different between each category in smoking, diabetes, hypertension, age, BMI, TG, TC, HDL-C (all *P*\<0.05); There were no difference between each category in DBP, HDL-C, and LDL-C in men; There were no significant difference between each category in glucose, TC, HDL-C, LDL-C and DBP in women.

10.1371/journal.pone.0015181.t001

###### Characteristics of participants.

![](pone.0015181.t001){#pone-0015181-t001-1}

                               Men           Women                                                                        
  ----------------------- -------------- ------------- ------------- --------- -------------- ------------- ------------- ---------
  Smoking (n, %)           1546 (62.6)    730 (43.5)    965 (55.8)    \<0.001    66 (2.46)      19 (0.82)    296 (15.6)    \<0.001
  Diabetes (n, %)           200 (8.09)     96 (5.72)     80 (4.63)    \<0.001    158 (5.88)    120 (5.15)     43 (2.67)    \<0.001
  Hypertension (n, %)      1109 (44.88)   613 (36.53)   953 (55.15)   \<0.001   1089 (40.54)   847 (36.35)   901 (47.50)   \<0.001
  Age (years)               51.2±12.8      52.2±13.4     48.7±11.9    \<0.001    52.1±11.8      48.8±12.4     47.9±11.2    \<0.001
  BMI (kg/m^2^)             25.68±3.23    25.47±4.07    26.96±4.29    \<0.001    24.50±3.60    25.97±4.51    26.23±5.19    \<0.001
  SBP (mmHg)                133.6±18.4    131.1±19.5    135.1±20.6    \<0.001    130.3±20.6    130.5±21.9    138.2±25.9     0.009
  DBP (mmHg)                87.3±15.1      80.4±14.6     89.9±18.4    \<0.001    82.7±15.7      79.5±15.2     86.1±20.0     0.005
  Uric acid (µmol/L)        341.7±86.9    284.7±77.2    294.7±77.3    \<0.001    270.9±70.4    222.0±62.1    226.5±64.0    \<0.001
  Glucose (mmol/L)          5.44±1.96      4.93±1.86     5.23±1.61    \<0.001    5.16±1.50      4.90±1.48     5.05±1.47     0.113
  Triglyceride (mmol/L)     1.97±1.69      1.66±1.46     1.34±1.08    \<0.001    1.46±1.10      1.60±1.14     1.09±0.65    \<0.001
  TC (mmol/L)               4.68±1.07      4.30±1.06     4.82±1.06    \<0.001    4.70±1.09      4.40±1.13     4.73±1.13    \<0.001
  HDL --C (mmol/L)          1.24±0.45      1.26±0.50     1.28±0.44     0.007     1.27±0.47      1.26±0.45     1.29±0.45     0.099
  LDL-C (mmol/L)            2.85±0.89      2.87±0.91     2.88±0.90     0.534     2.88±0.93      2.86±0.93     2.91±0.94     0.215

(Note:1 mm Hg  = 0.133 kPa; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL-C, high density lipoproteins cholesterol; LDL-C, low density lipoproteins cholesterol).

10.1371/journal.pone.0015181.t002

###### Cardiovascular Risks Factors According to Daily Alcohol Consumption Categories in Men.

![](pone.0015181.t002){#pone-0015181-t002-2}

                         Categories of Alcohol consumption (g/day)   *P* value                                                       
  --------------------- ------------------------------------------- ------------ ------------ ------------ ------------ ------------ ---------
  NO. of subjects                          2791                         420         1 440         795          214          217      
  Smoking (n, %)                        1782 (63.8)                  272 (64.8)   513 (35.6)   148 (18.6)   113 (52.8)   103 (47.5)   \<0.001
  Diabetes (n, %)                        243 (8.7)                    30 (7.1)    142 (9.9)     70 (8.8)    29 (13.6)    32 (14.7)     0.411
  Hypertension (n, %)                   1773 (63.5)                  221 (52.6)   382 (26.5)   176 (22.1)   77 (36.0)    146 (67.3)   \<0.001
  Age(years)                             51.9±13.3                   53.6±12.0    45.9±10.2    45.9±10.2    47.2±10.9    46.8±10.3    \<0.001
  BMI(kg/m^2^)                           25.7±3.9                     26.5±3.8     26.4±3.7     26.3±3.8     26.5±3.3     27.0±3.8    \<0.001
  SBP(mmHg)                             134.9±21.2                   136.0±20.0   133.9±19.1   132.6±18.7   136.5±18.6   137.2±18.7    0.048
  DBP(mmHg)                              85.4±16.7                   85.6±15.5    86.9±15.9    88.3±15.0    88.1±16.0    89.9±15.8    \<0.001
  Glucose (mmol/L)                       5.19±1.86                   5.20±1.75    5.36±1.88    5.22±1.22    5.40±2.09    5.37±1.78    \<0.001
  TG (mmol/L)                            1.55±1.34                   1.83±1.50    1.95±1.55    2.20±1.50    2.11±2.98    2.17±1.77    \<0.001
  TC (mmol/L)                            4.53±1.12                   4.76±1.12    4.75±1.00    4.84±0.99    4.73±1.10    4.82±1.23    \<0.001
  HDL -C(mmol/L)                         1.26±0.46                   1.24±0.45    1.22±0.41    1.30±0.52    1.23±0.45    1.27±0.47     0.243
  LDL-C (mmol/L)                         2.86±0.90                   2.92±0.95    2.84±0.89    2.83±0.86    2.78±0.83    2.93±0.89     0.311

Note:1 mm Hg  = 0.133 kPa; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, Triglyceride; TC, Total cholesterol.

10.1371/journal.pone.0015181.t003

###### Cardiovascular Risks Factors According to Daily Alcohol Consumption Categories in Women.

![](pone.0015181.t003){#pone-0015181-t003-3}

                         Categories of Alcohol consumption (g/day)   *P* value                                                       
  --------------------- ------------------------------------------- ------------ ------------ ------------ ------------ ------------ ---------
  NO. of subjects                          5 147                         82          1038         174          271          201      
  Smoking (n, %)                         355 (6.9)                   26 (31.7)    270 (26.0)   45 (25.9)    51 (18.8)    64 (31.8)    \<0.001
  Diabetes (n, %)                        316 (6.1)                    8 (9.8)      57 (5.5)     21 (7.1)    28 (13.9)     19 (9.5)    \<0.001
  Hypertension (n, %)                   2806 (54.5)                  27 (32.9)    404 (38.9)   76 (43.7)    121 (44.6)   87 (43.3)    \<0.001
  Age (years)                            49.8±12.0                   43.4±12.4    46.6±10.6    48.3±10.3     49.6±8.2     46.4±8.2     0.036
  BMI (kg/m^2^)                          25.5±4.5                     24.0±3.1     23.6±3.0     24.7±2.0     22.4±1.7     25.8±3.0     0.045
  SBP (mmHg)                            132.6±22.9                   125.4±20.4   123.6±20.0   129.0±16.7   132.7±21.1   139.5±19.9    0.013
  DBP (mmHg)                             82.5±17.0                   81.4±15.9    79.7±18.5    82.4±12.4    77.0±13.9    91.3±24.1     0.164
  Glucose (mmol/L)                       5.04±1.49                   4.96±1.24    5.37±2.19    4.39±0.33    4.53±0.39    4.97±1.14     0.629
  TG (mmol/L)                            1.40±1.03                   1.48±1.19    1.51±0.98    1.70±1.23    1.35±1.15    2.22±1.50     0.041
  TC (mmol/L)                            4.60±1.13                   4.48±0.79    4.65±0.95    4.94±0.73    4.51±0.80    4.90±1.14     0.863
  HDL --C (mmol/L)                       1.28±0.45                   1.29±0.55    1.18±0.36    1.13±0.31    1.19±0.30    1.31±0.57     0.762
  LDL-C (mmol/L)                         2.88±0.93                   2.89±1.05    2.64±0.90    2.86±1.22    2.42±0.68    2.74±0.82     0.510

Note:1 mm Hg  = 0.133 kPa; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, Triglyceride; TC, Total cholesterol.

Alcohol consumption and ABI and PAD {#s2b}
-----------------------------------

As was shown in [table 4](#pone-0015181-t004){ref-type="table"}, we observed a significant increase in ABI with increased alcohol consumption up to daily intake levels of 60 g in men (model 1, *P*\<0.001). But the ABI value of individual with daily alcohol level \>60 g/d was significantly lower than those never drink or than those with daily alcohol level \<60 g/d. After adjusted for the age, ethnicity, body mass index, smoking habits, GLU, and diabetes, the difference remains significant (model 2, *P*\<0.001); and when additional confounders including SBP, DBP, TG, TC, HDL-C, and LDL-C were adjusted, this relationship did not change (model 3, *P*\<0.001). The frequencies of PAD were different between alcohol categories. Either the unadjusted or multivariate-adjusted odds ratio (OR) for PAD was significantly higher in men who consumed \>60.0 g/d \[OR  = 3.857, (95% CI: 2.555--5.824); OR = 2.797, (95% CI: 1.106--3.129); OR = 2.878, (95% CI: 1.215--4.018); respectively\] and was significantly lower in men who consumed 20.1--40.0 g/d \[OR  = 0.330, (95% CI: 0.181--0.599); OR = 0.484, (95% CI: 0.065--0.894); OR = 0.478, (95% CI: 0.243--1.534); respectively\] and 40.1--60.0 g/d \[OR  = 0.306, (95% CI: 0.096--0.969); OR = 0.267, (95% CI: 0.087--0.886); OR = 0.203, (95% CI: 0.113--0.754); respectively\] compared with never drinking, respectively (all *P*\<0.01). Neither in unadjusted nor in multivariate-adjusted model the association between ABI and alcohol consumption was significant (all *P*\>0.05) in women. Similarly, PAD was not correlated with alcohol intake in women analyzed by each model (all *P*\>0.05) ([table 5](#pone-0015181-t005){ref-type="table"}).

10.1371/journal.pone.0015181.t004

###### Relation between Alcohol Consumption and ABI or PAD in Men.

![](pone.0015181.t004){#pone-0015181-t004-4}

                                                                              Categories of Alcohol consumption (g/day)   *P* [\*](#nt104){ref-type="table-fn"} value                                                                                              
  -------------------------------------------------------------------------- ------------------------------------------- --------------------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------
  NO. of subjects                                                                               2791                                          420                              1 440                   795                    214                    217           
  ABI                                                                                                                                                                                                                                                              
  Model 1[a](#nt107){ref-type="table-fn"} [‡](#nt106){ref-type="table-fn"}                   1.078±0.102                                  1.096±0.104                       1.103±0.096            1.095±0.116            1.099±0.094            1.065±0.086        \<0.001
  Model 2[b](#nt108){ref-type="table-fn"} [†](#nt105){ref-type="table-fn"}                   1.073±0.001                                  1.081±0.005                       1.095±0.004            1.081±0.007            1.093±0.008            1.069±0.004        \<0.001
  Model 3[c](#nt109){ref-type="table-fn"} [†](#nt105){ref-type="table-fn"}                   1.074±0.001                                  1.082±0.005                       1.095±0.004            1.077±0.007            1.090±0.008            1.055±0.004        \<0.001
  PDA (OR)                                                                                                                                                                                                                                                         
  Presence of PDA (n, %)                                                                     124 (4.44)                                    26 (6.19)                         45 (3.13)              12 (1.51)               3 (1.40)              33 (15.2)         \<0.001
  Model 1[a](#nt107){ref-type="table-fn"}                                                         1                                  1.419 (0.918--2.195)               0.694 (0.490--0.982)   0.330 (0.181--0.599)   0.306 (0.096--0.969)   3.857 (2.555--5.824)   \<0.001
  Model 2[b](#nt108){ref-type="table-fn"}                                                         1                                  1.365 (0.923--2.497)               1.086 (0.734--2.758)   0.484 (0.065--0.894)   0.267 (0.087--0.886)   2.797 (1.106--3.129)    0.002
  Model 3[c](#nt109){ref-type="table-fn"}                                                         1                                  1.473 (0.094--2.293)               1.121 (0.545--1.767)   0.478 (0.243--1.534)   0.203 (0.113--0.754)   2.878 (1.215--4.018)   \<0.001

\*P value was calculated by analysis of covariance using all categories of alcohol consumption.

Mean ± standard error of mean.

Mean ± standard deviation of mean.

:Unadjusted model;

:Only adjusted for age, ethnicity, body mass index, smoking habits, GLU, and diabetes.

:Adjusted for age, ethnicity, body mass index, diabetes, smoking habits, hypertension, SBP, DBP, GLU, TC, HDL cholesterol, and LDL cholesterol;

10.1371/journal.pone.0015181.t005

###### Relationship between Alcohol Consumption and ABI and PAD in Women.

![](pone.0015181.t005){#pone-0015181-t005-5}

                                                                              Categories of Alcohol consumption (g/day)   *P* [\*](#nt110){ref-type="table-fn"} value                                                                                              
  -------------------------------------------------------------------------- ------------------------------------------- --------------------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- -------
  NO. of subjects                                                                               5 147                                         82                                1038                   174                    271                    201           
  ABI                                                                                                                                                                                                                                                              
  Model 1[a](#nt113){ref-type="table-fn"} [‡](#nt112){ref-type="table-fn"}                   1.098±0.096                                  1.092±0.095                       1.100±0.089            1.086±0.112            1.098±0.082            1.102±0.094        0.338
  Model 2[b](#nt114){ref-type="table-fn"} [†](#nt111){ref-type="table-fn"}                   1.098±0.002                                  1.097±0.005                       1.105±0.004            1.088±0.008            1.100±0.008            1.104±0.004        0.301
  Model 3[c](#nt115){ref-type="table-fn"} [†](#nt111){ref-type="table-fn"}                   1.097±0.002                                  1.095±0.005                       1.104±0.004            1.090±0.007            1.102±0.008            1.106±0.004        0.203
  PAD (OR)                                                                                                                                                                                                                                                         
  Presence of PDA (n, %)                                                                     333 (6.47)                                    6 (7.32)                          60 (5.78)              11 (6.32)              14 (5.71)              16 (7.96)         0.802
  Model 1[a](#nt113){ref-type="table-fn"}                                                         1                                  1.141 (0.493--2.640)               0.887 (0.668--1.177)   0.976 (0.525--1.815)   0.788 (0.455--1.364)   1.250 (0.741--2.109)   0.804
  Model 2[b](#nt114){ref-type="table-fn"}                                                         1                                  1.101 (0.518--2.634)               0.568 (0.158--1.550)   0.875 (0.316--1.402)   0.764 (0.331--1.535)   1.214 (0.716--2.046)   0.199
  Model 3[c](#nt115){ref-type="table-fn"}                                                         1                                  1.144 (0.732--2.986)               0.598 (0.337--1.830)   0.886 (0.414--1.517)   0.765 (0.298--1.815)   1.301 (0.898--2.643)   0.187

\*P value was calculated by analysis of covariance using all categories of alcohol consumption.

Mean ± standard error of mean.

Mean ± standard deviation of mean.

:Unadjusted model;

: Only adjusted for age, ethnicity, body mass index, smoking habits, GLU, and diabetes.

: Adjusted for age, ethnicity, body mass index, smoking habits, BP, diabetes, GLU, TC, HDL cholesterol, and LDL cholesterol;

Discussion {#s3}
==========

In this study, we observed a significant increase in ABI with increased alcohol consumption up to daily intake levels of 60 g in Chinese men but not in women. And heavier drinking (\>60 g/d) can increase the risk of PAD in men but not in women. In other words, our results indicated that in Chinese men, alcohol consumption was associated with peripheral atherosclerosis, and consumption of less than 60 g/d had an inverse association with peripheral atherosclerosis whereas consumption of 60 g/d or more had a positive association.

Several studies have demonstrated that a low ABI is an independent predictor of cardiovascular risk[@pone.0015181-Migliacci1], [@pone.0015181-Nunez1]--[@pone.0015181-Criqui1], low ABI is more frequent in patients with cardiovascular risk factors such as smoking, diabetes, and hypertension and is inversely correlated with other measures of vascular disease, including microalbuminuri [@pone.0015181-Zheng1] and carotid intimal-medial thickness [@pone.0015181-Kobayashi1]--[@pone.0015181-Lorenz1]. In the previous studies, much research focus on the relationship between alcohol and carotid IMT, [@pone.0015181-Schminke1], [@pone.0015181-Mukamal1]--[@pone.0015181-Mukamal2] one of the risk factors of CVD, although they have come to conflicting conclusions. Therefore, the ABI, another risk factor of CVD, its association with alcohol intake should be worth paying close attention to. A few studies have assessed this relation but the results are discrepancy. Mukama et al. observed that consumption of 1--13 alcoholic drinks per week was associated with lower risk of hospitalized lower extremity arterial disease (LEAD) in older adults, with a similar trend for risk of decline in ABI over time, but heavier drinking was not associated with lower risk [@pone.0015181-Jepson1]. Jepson et al. found greater alcohol consumption was related to a higher ABI in males but not in females [@pone.0015181-Vliegenthart1]. And Vliegenthart observed an inverse association between alcohol consumption and PAD in nonsmoking men and women [@pone.0015181-Fabsitz1]. Fabsitz *et al*. found current alcohol consumption was significantly negatively associated with PAD [@pone.0015181-Sacanella1].

In our analysis, we observed moderate drinking may be a protective factor but heavier drinking could be a risk factor for peripheral arteriosclerosis in Chinese men. The mechanisms, which may link alcohol intake to ABI, are largely unknown. Theoretically, the ethanol and nonalcoholic components of alcoholic beverages have possible favorable effect on endothelium by reducing intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression of vascular endothelium, as well as monocyte adhesion [@pone.0015181-Leikert1]. Alcohol could also enhance nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells, leading to vasoprotective impact [@pone.0015181-Wallerath1], [@pone.0015181-Kauhanen1]. Therefore, alcohol consumption and ABI, like alcohol intake and IMT or other factors for CVD, showed a decreasing risk function at moderate drinking. But in our analysis, this relationship was observed only in men but not in women. This discrepancy may be explained (1) in our study, due to the affection by Chinese traditional culture, the majority of women were never drinkers, those who did drink, had a narrower range, and the alcohol consumption was categorized differently in men and women considering the metabolic difference by sex [@pone.0015181-Schminke1]. This fact may be a possible reason for this discrepancy; (2) alcohol ingestion results in significant alterations in sex hormone levels and function [@pone.0015181-Eagon1]. Alcoholic men and women often display different phenotypic changes due to an inability to maintain appropriate hormone balance. And the sex hormone have been demonstrated a significant association with cardiovascular disease, including arteriosclerosis; [@pone.0015181-Olsen1], [@pone.0015181-Traish1] (3) differences between men and women in histological characteristics and the stage of peripheral arteriosclerosis under study may be, at least in part, another important factor.

This study has several limitations. First, this study is questionnaire-derived estimates of self-reported alcohol intake which have been criticized because of underreporting, especially by heavy drinkers. Therefore in the present study, we validated self-reported alcohol intake against asking not only themselves but also their family members at the same time face to face or by telephone. Second, in the present study, because of the absence of a real and important confounder-the social disparities in our database, we did not inclusive this variable in the multivariable analysis. This may underestimate or overestimate the real association of alcohol with peripheral arteriosclerosis. Third, in the present study, we did not investigate the role of different type of alcoholic beverages, such as wine, beer, and liquor. Fourth, in our study, the number of women with never drink was far more than other alcohol consumption category, which was the fact of dinking in women of China. This fact may underestimate the association of alcohol intake with peripheral arteriosclerosis.

Several strengths include the inclusion of a large three-ethnic cohort of individuals from the community. We used uniform protocols in the three ethnic groups including questionnaires, anthropometric measurements, assessment of conventional risk factors, and the ABI measure. We separated former drinkers who had stopped drinking for health or other reasons from nondrinkers. Former drinkers have different characteristics from nondrinkers, and analyzing their data separately provided more accurate results.

Methods {#s4}
=======

Ethics Statement {#s4a}
----------------

The present study was conducted in accordance with the Declaration of Helsinki guidelines, and informed consent was obtained from each individual according to a protocol approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University.

Subjects {#s4b}
--------

The Cardiovascular Risk Survey (CRS) study is a multiple-ethnic, community-based, cross-sectional study designed to investigate the prevalence, incidence, and risk factors for cardiovascular diseases and to determine the genetic and environmental contributions to atherosclerosis, CAD and cerebral infarction (CI) of Chinese Han, Uygur, and Kazakh population in Xinjiang of west China from October 2007 to March 2010. We used a stratified sampling method to select a representative sample of the general population of Chinese Hans, Uygurs, and Kazakhs of this area. Seven cities (Urumqi, Kelamayi, Hetian, Zhaosu, Fukang, Tulufan, and Fuhai) were chosen and, based on the government record of registered residence, one participant was randomly selected from each household. In this way, a total of 14 618 participants (5 757 Hans, 4 767 Uygurs, and 4 094 Kazakhs), were randomly selected from 26 villages of these seven cities and were invited to participate. Patients with a previous cardiovascular event, such as myocardial infarction, stroke, and heart failure, have been excluded (677 of Han, 605 of Uygur, 490 of Kazakh) from the analysis. In addition, those whose data were incomplete (8 of Han, 20 of Uygur, 2 of Kazakh) and individual with ABI\>1.3 (26 subjects in total) were excluded. Finally, 12 790 individuals (87.49%) were analyzed in the present study.

Alcohol consumption {#s4c}
-------------------

In our study, to assess the drinking status of the study population, we used four questions as follows. The fist question was " Prior to this study, have you ever drunk alcoholic beverages? "; The second questions was "In the 12 months before the date of this study, do you drink alcoholic beverages? "; The third question was "On a day when you do drink alcohol, how many drinks do you usually have?"; The forth question was "How often do you have a drink containing alcohol, per week?". The persons who answered "no" to both the first question and the second question were classified as never-drinkers. The persons who answered "yes" to the first question and "no" to the second question were classified as former drinkers. The persons who answered "yes" to both the first question and the second question were defined as current drinkers. If the persons were defined as current drinkers, the third and the forth question must be answered. The amount of alcohol consumed per day was calculated from the average number of alcoholic beverages consumed. We categorized daily ethanol intake in grams into six categories for men: former, none, 0.1 to 20.0, 20.1 to 40.0, 40.1 to 60.0, and 60.1 gram or more and for women: never, former, 0.1--5.0, 5.1--10.0, 10.1--20.0, and \>20.0 gram or more. Participants were asked whether they changed their usual pattern of consumption and, if so, whether they have increased or decreased their consumption.

ABI Measurement {#s4d}
---------------

The ABI was measured in all subjects using the form ABI/PWV (VP1000; Colin, CO.,Ltd., Komaki, Japan) which is a device with four cuffs that can simultaneously measure blood pressure levels in both arms and both legs and automatically calculate the ankle brachial pressure index (ABI). The measure procedure was described by Ohnishi et al [@pone.0015181-Ohnishi1]. Briefly, the methods as follows: After a 5-min rest, subjects were evaluated in the supine position. The cuff was inflated to 10 mm Hg above SBP and deflated at 2 mm Hg/s. The first reappearance of the arterial signal was taken as the SBP. To calculate the ABI, the SBP at each ankle site (posterior tibial and dorsalis pedis arteries) was divided by the higher of the two brachial pressures. The lower of the average ABIs from the two legs was used in the analyses [@pone.0015181-Ali1]. PAD was diagnosed if the ABI was less than the cutoff value of 0.9. [@pone.0015181-Vliegenthart1]

Covariates {#s4e}
----------

We collected information on each subject\'s medical history and lifestyle characteristics using standardized questionnaires. Systemic arterial hypertension was defined as a systolic blood pressure of ≥140 mmHg and/or a diastolic blood pressure of ≥90 mmHg [@pone.0015181-Guidelines1], on at least two separate occasions, or anti-hypertensive treatment. Hypercholesterolaemia was defined as a documented total cholesterol value ≥240 mg/dl (≥6.2 mmol/L) or current treatment with cholesterol-lowering medication. Diabetes mellitus was defined as the presence of an active treatment with insulin or an oral antidiabetic agent; for patients on dietary treatment, documentation of an abnormal fasting blood glucose, or glucose tolerance test based on the World Health Organization criteria [@pone.0015181-World1] was required for establishing this diagnosis. Smoking status classifications were current smokers, and never-smokers. All participants underwent a standardized physical examination performed by experienced research staff. Anthropometric measurements were conducted in light clothing and without shoes. Height was measured to the nearest 0.1 cm, and weight was measured with a standard scale in the upright position to the nearest 0.1 kg. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m^2^). Waist circumference was measured to the nearest 0.1 cm at the midpoint between the lower border of the rib cage and the upper hip bone (iliac crest) during expiration.

Biochemical analysis {#s4f}
--------------------

Serum was separated from the samples within 30 min and stored at --80°C until analysis. We measured the serum concentration of triglyceride, total cholesterol, HDL and LDL cholesterol, fasting glucose and uric acid using equipment for chemical analysis (Dimension AR/AVL Clinical Chemistry System, Newark, NJ) employed by the Clinical Laboratory Department of the First Affiliated Hospital of Xinjiang Medical University as described previously. [@pone.0015181-Xie1]--[@pone.0015181-Xie2]

Statistical analysis {#s4g}
--------------------

Data analysis was performed using the computer software *Statistical Package for Social Sciences-SPSS* for Windows (version 17.0). Demographic and clinical characteristics of the study population were expressed as the mean ± standard deviation or as a ratio based on the alcohol consumption categories. ABI were presented as the mean ± standard deviation in the unadjusted model and the mean ± standard error of the mean in the multivariable models. Differences in cardiovascular risk factors and in ABI according to alcohol consumption categories were adjusted for gender and tested by analysis of covariance for quantitative variables. Multivariate associations between alcohol consumption categories and ABI and PAD were tested using analysis of covariance and multiple regressions. To test the linear trends of associations between alcohol consumption and ABI, the categories of alcohol consumption were treated as a continuous variable, excluding former drinkers. The odds ratio for PAD was calculated by binary logistic regression analysis.
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